Published May 2, 2018
Jun Qu, PhD, has been promoted to the rank of Professor of Pharmaceutical Sciences at the University at Buffalo School of Pharmacy and Pharmaceutical Sciences.
Qu has defined methodologies and advanced scientific knowledge that will change the way cancer, infection and heart disease are diagnosed and treated. His research focuses on protein and drug analysis using liquid chromatography mass spectrometry (LC/MS) to discover new knowledge and develop novel research techniques that are applied throughout the field of clinical and pharmaceutical proteomics. His lab is one of the top labs in the world on label-free proteomics for large-scale analysis; he is also a world leader in the field of characterization of antibody therapeutics using LC/MS.
After earning a PhD in analytical chemistry from China’s prestigious Tsinghua University, Qu decided to pursue an academic career in biomedical research. He joined the SPPS faculty as a Research Assistant Professor of Pharmaceutical Sciences in 2004.
Qu also currently serves in adjunct positons in ophthamology and biochemistry at the University at Buffalo and Roswell Park Cancer Institute.
As either principal investigator or co-investigator, he has received a total of $4.7 million grants from the National Institutes of Health (NIH), the National Science Foundation (NSF), private foundations, and various pharmaceutical companies.
Qu boasts over 100 peer-reviewed original journal articles and is a member of numerous professional organizations, including the American Association of Pharmaceutical Scientists, the American Heart Association, the International Society of Heart Research and the American Society of Mass Spectrometry.
He received a University at Buffalo Clinical and Translations Science Institute Pilot Studies Award in both 2014 and 2016. He was the recipient of the 2015 Outstanding Contribution Award for Medicinal Analysis by the Chinese Society of Pharmaceutical Analysis, in recognition of his contribution to the development and application of novel LC/MS-based methods for characterization of biologics and protein markers. He was also a recipient of the 2015 Thermo Fisher Scientific Tandem Mass Tag Research Award for his innovation and potential impact in the field of proteomics.